BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12722881)

  • 1. von Hippel-Lindau disease: recent advances and therapeutic perspectives.
    Richard S;
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):215-33. PubMed ID: 12722881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
    Richard S; Martin S; David P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Von Hippel-Lindau disease: recent advances in genetics and clinical management].
    Richard S; Parker F; Aghakhani N; Allegre G; Portier F; David P; Marsot-Dupuch K
    J Neuroradiol; 2005 Jun; 32(3):157-67. PubMed ID: 16134297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From gene to disease; Von Hippel-Lindau disease].
    Hes FJ; Los M; van der Luijt RB
    Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1364-7. PubMed ID: 12162174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
    Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
    Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization.
    Pack SD; Zbar B; Pak E; Ault DO; Humphrey JS; Pham T; Hurley K; Weil RJ; Park WS; Kuzmin I; Stolle C; Glenn G; Liotta LA; Lerman MI; Klausner RD; Linehan WM; Zhuang Z
    Cancer Res; 1999 Nov; 59(21):5560-4. PubMed ID: 10554035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
    Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
    Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Hippel-Lindau: how a rare disease illuminates cancer biology.
    Richard S; Gardie B; Couvé S; Gad S
    Semin Cancer Biol; 2013 Feb; 23(1):26-37. PubMed ID: 22659535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetics and angiogenesis: the example of von Hippel-Lindau disease].
    Richard S; Ladroue C; Gad S; Giraud S; Gardie B;
    Bull Cancer; 2007 Jul; 94 Spec No():S170-9. PubMed ID: 17846002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
    Richard S; Beroud C; Joly D; Chretien Y; Benoit G
    Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
    Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
    J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease.
    Granata A; Sessa A; Righetti M; Cordaro S; Leone G; Figura M; Fatuzzo P; Rapisarda F; Di Maria E; Ciotti P; Mandich P; Nardo A; Ferrone M; Gallone S; Liuzzo G
    J Nephrol; 2004; 17(2):306-10. PubMed ID: 15293534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Hippel-Lindau disease: a genetic condition predisposing tumor formation.
    Martz CH
    Oncol Nurs Forum; 1991 Apr; 18(3):545-51. PubMed ID: 2057398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The history of von Hippel-Lindau disease.
    Molino D; Sepe J; Anastasio P; De Santo NG
    J Nephrol; 2006; 19 Suppl 10():S119-23. PubMed ID: 16874724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of a de novo mutation in a patient without von Hippel-Lindau syndrome: clinical and diagnostic implications].
    Cebrián A; Ruiz Barnés P; Osorio A; Martínez-Delgado B; Benítez J; Robledo M
    Neurologia; 1999; 14(7):362-5. PubMed ID: 10570625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between VHL genotype and clinical phenotype in familial von Hippel-Lindau disease.
    Huang JS; Huang CJ; Chen SK; Chien CC; Chen CW; Lin CM
    Eur J Clin Invest; 2007 Jun; 37(6):492-500. PubMed ID: 17537157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification.
    Hes FJ; van der Luijt RB; Janssen AL; Zewald RA; de Jong GJ; Lenders JW; Links TP; Luyten GP; Sijmons RH; Eussen HJ; Halley DJ; Lips CJ; Pearson PL; van den Ouweland AM; Majoor-Krakauer DF
    Clin Genet; 2007 Aug; 72(2):122-9. PubMed ID: 17661816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [von Hippel-Lindau syndrome: molecular diagnosis of two Lebanese families and analysis of the genotype-phenotype correlation].
    Medlej-Hashim M; Leclercq A; Salem N; Moukarzel M; Merhej S; Pigny P; Megarbane A
    J Med Liban; 2004; 52(1):51-4. PubMed ID: 15881703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutation of von Hippel-Lindau (VHL) gene 695 G>A (R161Q) in a patient with a peculiar phenotype with type 2C VHL syndrome.
    Santarpia L; Lapa D; Benvenga S
    Ann N Y Acad Sci; 2006 Aug; 1073():198-202. PubMed ID: 17102087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.